Particularly, the mechanisms through which BAG2 contributes to epithelial-mesenchymal transition by inhibiting the degradation of mutant p53 [7] or its interaction with microRNA-1180 [26] in cancer cells have been determined. The gene discussed is TP53; the disease is cancer.